請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74167
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳文鍾(Wen-Jone Chen) | |
dc.contributor.author | Jin-Lin Chang | en |
dc.contributor.author | 張覲麟 | zh_TW |
dc.date.accessioned | 2021-06-17T08:22:39Z | - |
dc.date.available | 2019-08-27 | |
dc.date.copyright | 2019-08-27 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-13 | |
dc.identifier.citation | Ames 3rd A, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol 1968;52:437–53.
Becker LB, Aufderheide TP, Geocadin RG, Callaway CW, Lazar RM, Donnino MW, et al. Primary outcomes for resuscitation science studies: a consensus statement from the American Heart Association. Circulation 2011;124:2158–77. Beiser DG, Carr GE, Edelson DP, Peberdy MA, Hoek TL. Derangements in blood glucose following initial resuscitation from in-hospital cardiac arrest: a report from the national registry of cardiopulmonary resuscitation. Resuscitation 2009;80:624–30. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137:e67–e492. doi:10.1161/CIR.0000000000000558 Borgquist O, Wise MP, Nielsen N, Al-Subaie N, Cranshaw J, Cronberg T, et al. Dysglycemia, glycemic variability, and outcome after cardiac arrest and temperature management at 33 degrees C and 36 degrees C. Crit Care Med 2017;45:1337–43. Braemswig TB, Nolte CH, Fiebach JB, Usnich T. Early new ischemic lesions located outside the initially affected vascular territory appear more often in stroke patients with elevated glycated hemoglobin (HbA1c). Front Neurol 2017;8:606. Callaway CW, Donnino MW, Fink EL, Geocadin RG, Golan E, Kern KB, et al. Part 8: post-cardiac arrest care 2015 American Heart Association Guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015;132:S465–82. Cueni-Villoz N, Devigili A, Delodder F, Cianferoni S, Feihl F, Rossetti AO, et al. Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest. Crit Care Med 2011;39:2225–31. Daviaud F, Dumas F, Demars N, Geri G, Bouglé A, Morichau-Beauchant T, et al. Blood glucose level and outcome after cardiac arrest: insights from a large registry in the hypothermia era. Intens Care Med 2014;40:855–62. Echouffo-Tcheugui JB, Kolte D, Khera S, Bhatt DL, Fonarow GC. Comparison of survival after in-hospital cardiac arrest in patients with versus without diabetes mellitus. Am J Cardiol 2018;121:671–7. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 2008;36:2249–55 Eslami S, de Keizer NF, de Jonge E, Schultz MJ, Abu-Hanna A. A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset. Crit Care 2008;12:R139. Ettleson MD, Arguello V, Wallia A, Arguelles L, Bernstein RA, Molitch ME. Hyperglycemia and insulin resistance in cardiac arrest patients treated with moderate hypothermia. J Clin Endocrinol Metab 2014;99:E2010–4. Girotra S, Nallamothu BK, Spertus JA, Li Y, Krumholz HM, Chan PS, et al. Trends in survival after in-hospital cardiac arrest. N Engl J Med 2012;367:1912–20. Glycemic Targets. Diabetes Care 2016;39:S39–46 Hastie TJ, Tibshirani RJ. Generalized additive models. London and New York: Chapman & Hall; 1990. Hou Q, Zuo Z, Michel P, Zhang Y, Eskandari A, Man F, et al. Influence of chronic hyperglycemia on cerebral microvascular remodeling: an in vivo study using perfusion computed tomography in acute ischemic stroke patients. Stroke 2013;44:3557–60. Jacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L, et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation 2004;110:3385–97. Joy MS, Cefalu WT, Hogan SL, Nachman PH: Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 39: 297–307, 2002 Kamouchi M, Matsuki T, Hata J, Kuwashiro T, Ago T, Sambongi Y, et al. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry. Stroke 2011;42:2788–94. Kim SH, Park KN, Choi SP, Kim YM, Kim HJ, Oh SH, et al. Time to reach target glucose level and outcome after cardiac arrest patients treated with therapeutic hypothermia. J Crit Care 2015;30:1204–9. Kim JS, Kim RY, Cha JK, Rha HW, Kang MJ, Kim DH, et al. Pre-stroke glycemic control is associated with early neurologic deterioration in acute atrial fibrillationrelated ischemic stroke. eNeurologicalSci 2017;8:17–21. Liao WI, Wang JC, Chang WC, Hsu CW, Chu CM, Tsai SH. Usefulness of glycemic gap to predict ICU mortality in critically ill patients with diabetes. Medicine (Baltimore) 2015;94:e1525. Liao WI, Lin CS, Lee CH, Wu YC, Chang WC, Hsu CW, et al. An elevated glycemic gap is associated with adverse outcomes in diabetic patients with acute myocardial infarction. Sci Rep 2016;6:27770. Mackenzie IM, Whitehouse T, Nightingale PG. The metrics of glycaemic control in critical care. Intens Care Med 2011;37:435–43. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ,et al. Heart disease and stroke statistics-2016update: a report from the American Heart Association. Circulation 2016;133:e38–360. Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 2007;50:2239–44. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473–8. Nolan JP, Neumar RW, Adrie C, Aibiki M, Berg RA, Böttiger BW, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A scientific statement from the international liaison committee on resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation 2008;79:350–79. Nolan JP, Soar J, Cariou A, Cronberg T, Moulaert VR, Deakin CD, et al. European resuscitation council and European society of intensive care medicine guidelines for post-resuscitation care 2015: section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation 2015;95:202–22. Parry M, Danielson K, Brennenstuhl S, Drennan IR, Morrison LJ. The association between diabetes status and survival following an out-of-hospital cardiac arrest: a retrospective cohort study. Resuscitation 2017;113:21–6. Perman SM, Stanton E, Soar J, Berg RA, Donnino MW, Mikkelsen ME, Edelson DP, Churpek MM, Yang L, Merchant RM. Location of in-hospital cardiac arrest in the United States: variability in event rate and outcomes. J Am Heart Assoc. 2016;5:e003638. Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O’Dea H, Stranks SN, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab 2015;100:4490–7. Russo JJ, James TE, Hibbert B, Ramirez FD, Simard T, Osborne C, et al. Hyperglycaemia in comatose survivors of out-of-hospital cardiac arrest. Eur Heart J Acute Cardiovasc Care 2016. 2048872616684685. Sah Pri A, Chase JG, Pretty CG, Shaw GM, Preiser JC, Vincent JL, et al. Evolution of insulin sensitivity and its variability in out-of-hospital cardiac arrest (OHCA) patients treated with hypothermia. Crit Care 2014;18:586. Stecker EC, Reinier K, Marijon E, Narayanan K, Teodorescu C, Uy-Evanado A, Gunson K, Jui J, Chugh SS. Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol. 2014;7:212– 217. doi: 10.1161/CIRCEP.113.001034. Wang CH, Huang CH, Chang WT, Tsai MS, Yu PH, We YW, Chen WJ. Outcome of adults with in-hospital cardiac arrest after implantation of the 2010 resuscitation guidelines. International Journal of Cardiology. 2017;249: 214-219. Wolfson Jr SK, Safar P, Reich H, Clark JM, Gur D, Stezoski W, et al. Dynamic heterogeneity of cerebral hypoperfusion after prolonged cardiac arrest in dogs measured by the stable xenon/CT technique: a preliminary study. Resuscitation 1992;23:1–20. Woo JH, Lim YS, Yang HJ, Hyun SY, Cho JS, Kim JJ, et al. The relationship between the decreased rate of initial blood glucose and neurologic outcomes in survivors of out-of-hospital cardiac arrest receiving therapeutic hypothermia. Neurocrit Care 2017;26:402–10. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74167 | - |
dc.description.abstract | 研究背景
現在的急救流程中,對於院內呼吸心跳休止(In-hospital cardiac arrest, IHCA)經復甦後急救的病患,並沒有明確制訂關於目標血糖(Target glucose)的控制。在歐洲急救協會以及美國心臟科協會指引中,雖然有提到關於病患血糖之控制,但仍然著墨不多。此外,經急救恢復自主循環之病人,能出院比例很低,更遑論能恢復良好的神經學預後,恢復獨立或半獨立生活。因此,如何增加心跳休止病患後續之神經學預後,一直是很重要的議題。 而糖化血色素(Glycosalated haemoglobin, HbA1c)是我們臨床上經常使用來檢測糖尿病患者近期血糖控制的指數。在多方的研究中,目前已知病患血糖和其神經學預後有相關性。然而糖化血色素,是否可以應用在心跳休止經急救後復甦病患之血糖調控,以及其神經學預後否有相關,卻沒有相關的文獻探討。因此,本研究擬探討院內心跳休止病患之糖化血色素值、急救後復甦初期的測量血糖值以及其後續神經學預後之關係。 研究方法與結果 我們回溯了2006年至2015年間,單一醫學中心之院內心跳休止之病患共141位,並收集其3個月內之糖化血色素,以及急救後復甦24小時內,最高以及最低血糖值來加以分析。 在141位病患中,其糖化血色素之平均值為7.2%,換算出來的預估血糖平均值(Estimate average glucose, eAG)為160.2mg/dL。如心跳休止之病患之預估血糖值小於196mg/dL(糖化血色素之換算值為 8.5%)時,病患會有比較佳之神經學預後(OR: 5.12; 95% CI: 1.11-23.70; p-value=0.04);當最小之血糖差值差距(Minimum glycaemic gap)小於70mg/dL時,也會有同樣較佳之神經學預後(OR:5.41; 95% CI: 1.41-20.78; p-value = 0.01)。 本研究結果顯示,院內心跳休止經急救後復甦之糖尿病患,其長期血糖調控和神經學預後有關;且病患之糖化血色素也許可以做為該族群後續血糖調控之指標。然而該結果仍然需要後續前瞻性研究來加以驗證。 | zh_TW |
dc.description.abstract | Aim
Resuscitation guidelines do not recommend a target blood glucose (BG) level specifically tailored for diabetics experiencing an in-hospital cardiac arrest (IHCA). The glycosylated haemoglobin (HbA1c) level may be associated with neurological prognosis and used to identify the optimal BG level for diabetic IHCA patients. Methods This study was a retrospective study in a single medical center. Patients with an IHCA between 2006 and 2015 were screened. The estimated average glucose (eAG) level was converted from the HbA1c level measured within three months prior to the IHCA. The minimum glycaemic gap was calculated from the post resuscitation minimum BG level minus the eAG level. Results: A total of 141 patients were included in this study. The mean HbA1c was 7.2% (corresponding eAG: 160.2 mg/dL [8.9 mmol/L]). Multivariable logistic regression analysis indicated an eAG level of less than 196 mg/dL (10.9 mmol/L; corresponding HbA1c: 8.5%) was positively associated with a favourable neurological outcome at hospital discharge (odds ratio [OR]: 5.12, 95% confidence interval [CI]: 1.11–23.70; p-value=0.04). An absolute minimum glycaemic gap of less than 70 mg/dL (3.9 mmol/L) was also positively associated with a favourable neurological outcome (OR: 5.41, 95% CI: 1.41–20.78; p-value=0.01). Conclusion: For diabetic patients, poor long-term glycaemic control correlated with worse neurological recovery following an IHCA. The HbA1c-derived average BG level could be used as a reference point for glycaemic management during the early stage of post-cardiac arrest syndrome. The glycaemic gap could be used to identify the optimal glycaemic range around the reference point. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T08:22:39Z (GMT). No. of bitstreams: 1 ntu-108-P05421014-1.pdf: 1285263 bytes, checksum: 659fbee17d46bef28200b89f5f1d9f1a (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 口試委員會審定書…………………………i
誌謝…………………………ii 中文摘要…………………………iii 英文摘要…………………………v 碩士論文內容 第一章 緒論…………………………1 第一節 關於院內心跳休止的流行病學…………………………1 第二節 重症病患血糖控制與急救後復甦之相關文獻回顧…………………………3 第三節 糖化血色素以及血糖差值之臨床意義…………………………5 第四節 欲研究的問題、假說以及其重要性…………………………7 第五節 目的…………………………7 第二章 研究方法與材料…………………………8 第一段 研究設計與背景…………………………8 第二段 研究樣本…………………………8 第三段 病患資料收集方法…………………………9 第四段 結果變項…………………………10 第五段 統計資料…………………………10 第三章 結果…………………………12 第一節 病患之血糖濃度分析…………………………12 第二節 血糖與神經學預後…………………………13 第四章 討論…………………………14 第一段 長期血糖調控與神經學預後…………………………14 第二段 血糖差值與目標化血糖值…………………………16 第三段 病患之糖化血色素差異…………………………18 第四段 研究限制…………………………18 第五章 結論與展望…………………………20 第六章 論文英文簡述…………………………22 第七章 參考文獻…………………………28 第八章 圖表…………………………34 附錄:碩士班修業期間所發表之相關論文清冊 | |
dc.language.iso | zh-TW | |
dc.title | 院內心跳休止病患之長期血糖、血糖差值與其神經學預後之相關性 | zh_TW |
dc.title | The association between long-term glycaemic control, glycaemic gap and neurological outcome of in-hospital cardiac arrest in diabetics: A retrospective cohort study | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 楊偉勛(Wei-Shiung Yang),張維典(Wei-Tien Chang) | |
dc.subject.keyword | 院內心跳休止,心肺復甦術,糖化血色素,血糖差值, | zh_TW |
dc.subject.keyword | In-hospital cardiac arrest,Resuscitation,Blood glucose,HbA1c, | en |
dc.relation.page | 42 | |
dc.identifier.doi | 10.6342/NTU201902681 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-08-14 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 1.26 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。